Gainers ENDRA Life Sciences (NASDAQ:NDRA) shares rose 10.8% to $5.94 during Tuesday's after-mar

Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.08) per share which beat the analy

Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark

Kelowna, British Columbia – July 6, 2026 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX) (th

KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company"

Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innova

Kelowna, British Columbia – June 25, 2026 - TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX) (t

KELOWNA, BC / ACCESS Newswire / June 25, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company

Potentially valuable novel compositions being investigated Lexaria also receives additional new gran

Potentially Valuable Novel Compositions Being Investigated Lexaria Also Receives Additional New Gran

More people than ever taking GLP-1 drugs for weight loss Growing list of diseases now indicated as t

More People Than Ever Taking GLP-1 Drugs for Weight Loss Growing List of Diseases Now Indicated as T

Retatrutide and amycretin are being investigated for compatibility with Lexaria's proprietary Dehydr

Retatrutide and amycretin are being investigated for compatibility with Lexaria's proprietary Dehydr

KELOWNA, BC / ACCESS Newswire / June 3, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or

Kelowna, British Columbia - June 3 , 2026 – TheNewswire - Lexaria Bioscience Corp. (NASDAQ: LEXX) (“

Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innova

KELOWNA, BC / ACCESS Newswire / May 19, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or

CEO Rich Christopher Discusses Recently Announced Material Transfer Agreement Extension and 2026 Res

CEO Rich Christopher Discusses Recently Announced Material Transfer Agreement Extension and 2026 Res

Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innova

KELOWNA, BC / ACCESS Newswire / May 5, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or t

Inaugural Episode Features CEO Rich Christopher on DehydraTECH Platform, GLP-1 Market Opportunity an

Inaugural Episode Features CEO Rich Christopher on DehydraTECH Platform, GLP-1 Market Opportunity, a

Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innova

Kelowna, British Columbia – TheNewswire - April 29, 2026 – Lexaria Bioscience Corp. (NASDAQ: LEXX) (

KELOWNA, BC / ACCESS Newswire / April 29, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" o

Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innov

Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innov

Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.06) per share which beat the analy

Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innov

Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innov

Exciting new human and animal studies designed to enhance business opportunitiesKELOWNA, BC / ACCESS

Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innov

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a

HC Wainwright & Co. analyst Yi Chen maintains Lexaria Bioscience (NASDAQ:LEXX) with a Buy and

Lexaria says its oral GLP-1 cut total adverse events nearly 48% versus Novo's Rybelsus, with com

DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus®DehydraTECH-sema

Lexaria Bioscience Corp. (NASDAQ:LEXX)(LEXXW) (the "Company" or "Lexaria"), a global

Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announc